Literature DB >> 14504700

Remodeling and skeletal fragility.

.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 14504700     DOI: 10.1007/s00198-003-1466-4

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  17 in total

1.  Absorbability and cost effectiveness in calcium supplementation.

Authors:  R P Heaney; M S Dowell; J Bierman; C A Hale; A Bendich
Journal:  J Am Coll Nutr       Date:  2001-06       Impact factor: 3.169

2.  High bone turnover is intrinsically harmful: two paths to a similar conclusion. The Parfitt view.

Authors:  A Michael Parfitt
Journal:  J Bone Miner Res       Date:  2002-08       Impact factor: 6.741

3.  Radiocalcium studies of bone formation rate in human metabolic bone disease.

Authors:  R P HEANEY; G D WHEDON
Journal:  J Clin Endocrinol Metab       Date:  1958-11       Impact factor: 5.958

4.  Dynamic bone remodeling in later Pleistocene fossil hominids.

Authors:  S Abbott; E Trinkaus; D B Burr
Journal:  Am J Phys Anthropol       Date:  1996-04       Impact factor: 2.868

5.  Bisphosphonate effects and the bone remodeling transient.

Authors:  R P Heaney; A J Yates; A C Santora
Journal:  J Bone Miner Res       Date:  1997-08       Impact factor: 6.741

6.  Menopausal changes in bone remodeling.

Authors:  R P Heaney; R R Recker; P D Saville
Journal:  J Lab Clin Med       Date:  1978-12

7.  Primary hyperparathyroidism and the risk of fracture: a population-based study.

Authors:  S Khosla; L J Melton; R A Wermers; C S Crowson; W m O'Fallon; B l Riggs
Journal:  J Bone Miner Res       Date:  1999-10       Impact factor: 6.741

8.  Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.

Authors:  Somnath Sarkar; Bruce H Mitlak; Mayme Wong; John L Stock; Dennis M Black; Kristine D Harper
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

9.  Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage.

Authors:  J Li; T Mashiba; D B Burr
Journal:  Calcif Tissue Int       Date:  2001-11       Impact factor: 4.333

10.  Bone histomorphometry in hypoparathyroid patients treated with vitamin D.

Authors:  B L Langdahl; L Mortensen; A Vesterby; E F Eriksen; P Charles
Journal:  Bone       Date:  1996-02       Impact factor: 4.398

View more
  10 in total

Review 1.  The elusive concept of bone quality.

Authors:  Robert R Recker; M Janet Barger-Lux
Journal:  Curr Osteoporos Rep       Date:  2004-09       Impact factor: 5.096

2.  Basic fibroblast growth factor improves trabecular bone connectivity and bone strength in the lumbar vertebral body of osteopenic rats.

Authors:  Wei Yao; Tamer Hadi; Yebin Jiang; Jeff Lotz; Thomas J Wronski; Nancy E Lane
Journal:  Osteoporos Int       Date:  2005-08-05       Impact factor: 4.507

Review 3.  Denosumab: What's new?

Authors:  Cesar E Bogado; Maria Belen Zanchetta; Juan A Boailchuk; Fabio E Massari; Jose R Zanchetta
Journal:  Curr Osteoporos Rep       Date:  2011-03       Impact factor: 5.096

Review 4.  Current and future treatment options in osteoporosis.

Authors:  Linda Brewer; David Williams; Alan Moore
Journal:  Eur J Clin Pharmacol       Date:  2011-02-16       Impact factor: 2.953

Review 5.  Denosumab: anti-RANKL antibody.

Authors:  Paul D Miller
Journal:  Curr Osteoporos Rep       Date:  2009-03       Impact factor: 5.096

6.  Epidemiology of fracture risk in the Women's Health Initiative.

Authors:  Rebecca D Jackson; Sirisha Donepudi; Walter Jerry Mysiw
Journal:  Curr Osteoporos Rep       Date:  2008-12       Impact factor: 5.096

7.  Reference Intervals for Bone Histomorphometric Measurements Based on Data from Healthy Premenopausal Women.

Authors:  Shijing Qiu; George Divine; Elizabeth Warner; Sudhaker D Rao
Journal:  Calcif Tissue Int       Date:  2020-08-20       Impact factor: 4.333

8.  Bone safety with risedronate: histomorphometric studies at different dose levels and exposure.

Authors:  R R Recker; L-G Ste-Marie; P Chavassieux; M R McClung; M W Lundy
Journal:  Osteoporos Int       Date:  2014-10-11       Impact factor: 4.507

Review 9.  Bone turnover markers: understanding their value in clinical trials and clinical practice.

Authors:  R Civitelli; R Armamento-Villareal; N Napoli
Journal:  Osteoporos Int       Date:  2009-02-04       Impact factor: 4.507

10.  Impaired bone formation in ovariectomized mice reduces implant integration as indicated by longitudinal in vivo micro-computed tomography.

Authors:  Zihui Li; Gisela Kuhn; Michael Schirmer; Ralph Müller; Davide Ruffoni
Journal:  PLoS One       Date:  2017-09-14       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.